These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 24085423)
41. Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells. Tao SF; Zhang CS; Guo XL; Xu Y; Zhang SS; Song JR; Li R; Wu MC; Wei LX World J Gastroenterol; 2012 May; 18(19):2334-43. PubMed ID: 22654424 [TBL] [Abstract][Full Text] [Related]
42. Changes in gene expression and assessment of DNA methylation in primary human hepatocytes and HepG2 cells exposed to the environmental contaminants-Hexabromocyclododecane and 17-beta oestradiol. Aniagu SO; Williams TD; Chipman JK Toxicology; 2009 Feb; 256(3):143-51. PubMed ID: 19027819 [TBL] [Abstract][Full Text] [Related]
43. [No correlation between the sensitivity to 5-aza-dC and the global DNA methylation level in hepatocellular carcinoma cells]. Li XP; Huang AL; Yang M Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):284-7. PubMed ID: 20460049 [TBL] [Abstract][Full Text] [Related]
44. [The Study of Methylated Regulation MicroRNA in Pancreatic Carcinoma Cell and Its Effect on Cell Proliferation,Migration and Invasion]. Hu KF; Yang QY; Dong JY; Yang XL; Peng H; Chen LH; Sun Y; Ma LZ; Liu J Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):819-823. PubMed ID: 29260513 [TBL] [Abstract][Full Text] [Related]
45. [5-azacytidine suppresses K562 cell line proliferation by down-regulation of miR-17-19b]. Yang Y; Li YH; Gao L; Wang LL; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1451-4. PubMed ID: 21176349 [TBL] [Abstract][Full Text] [Related]
46. microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line. Ueki S; Murakami Y; Yamada S; Kimura M; Saito Y; Saito H BMC Cancer; 2016 Sep; 16(1):732. PubMed ID: 27629773 [TBL] [Abstract][Full Text] [Related]
47. Modifying effects of 5-azacytidine on metal-containing proteins profile in Guerin carcinoma with different sensitivity to cytostatics. Chekhun VF; Lozovska YV; Naleskina LA; Borikun TV; Burlaka AP; Todor IN; Demash DV; Yalovenko TM; Zadvornyi TV; Pavlova AO; Storchay DM; Lukianova NY Exp Oncol; 2016 Dec; 38(4):283-287. PubMed ID: 28230826 [TBL] [Abstract][Full Text] [Related]
48. Tissue-specific and de novo promoter methylation of the mouse glucose transporter 2. Jin B; Seong JK; Ryu DY Biol Pharm Bull; 2005 Nov; 28(11):2054-7. PubMed ID: 16272688 [TBL] [Abstract][Full Text] [Related]
49. Mineral pitch induces apoptosis and inhibits proliferation via modulating reactive oxygen species in hepatic cancer cells. Pant K; Gupta P; Damania P; Yadav AK; Gupta A; Ashraf A; Venugopal SK BMC Complement Altern Med; 2016 May; 16():148. PubMed ID: 27233240 [TBL] [Abstract][Full Text] [Related]
50. [MicroRNA Methylation in the Diagnosis and Treatment of Hepatocellular Carcinoma]. Zhang HL; Yan J; Li X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):678-685. PubMed ID: 36065702 [TBL] [Abstract][Full Text] [Related]
51. Comparative Transcriptomic Analysis of Three Common Liver Cell Lines. Arzumanian V; Pyatnitskiy M; Poverennaya E Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240140 [TBL] [Abstract][Full Text] [Related]
52. Low doses of the carcinogen furan alter cell cycle and apoptosis gene expression in rat liver independent of DNA methylation. Chen T; Mally A; Ozden S; Chipman JK Environ Health Perspect; 2010 Nov; 118(11):1597-602. PubMed ID: 20562052 [TBL] [Abstract][Full Text] [Related]
53. [Research progress of microRNAs in regulation of lipid metabolism-related proteins for influencing the pathogenesis of hepatocellular carcinoma]. Lin YX; An FM; Zhan Q Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):219-222. PubMed ID: 30929341 [TBL] [Abstract][Full Text] [Related]
55. A Three-Pronged Epigenetic Approach to the Treatment of Hepatocellular Carcinoma. Hlady RA; Robertson KD Hepatology; 2018 Oct; 68(4):1226-1228. PubMed ID: 30070376 [No Abstract] [Full Text] [Related]
56. DNA methylation in hepatocellular carcinoma: what is the use? Dekervel J; van Pelt J; Verslype C Hepat Oncol; 2015 Oct; 2(4):321-323. PubMed ID: 30191011 [No Abstract] [Full Text] [Related]
57. Retraction notice to "Geniposide plays anti-tumor effects by down-regulation of microRNA-224 in HepG2 and Huh7 cell lines" [Experimental and Molecular Pathology 112 (2020) 104349]. Yu X; Wang Y; Tao S; Sun S Exp Mol Pathol; 2022 Jun; 126():104775. PubMed ID: 35461723 [No Abstract] [Full Text] [Related]
58. Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis. Takaki Y; Saito Y; Takasugi A; Toshimitsu K; Yamada S; Muramatsu T; Kimura M; Sugiyama K; Suzuki H; Arai E; Ojima H; Kanai Y; Saito H Cancer Sci; 2014 Oct; 105(10):1254-60. PubMed ID: 25117675 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA‑122 regulation of the morphology and cytoarchitecture of hepatoma carcinoma cells. Jin JC; Zhang X; Jin XL; Qian CS; Jiang H; Ruan Y Mol Med Rep; 2014 Apr; 9(4):1376-80. PubMed ID: 24504483 [TBL] [Abstract][Full Text] [Related]
60. Antitumor function of microRNA-122 against hepatocellular carcinoma. Nakao K; Miyaaki H; Ichikawa T J Gastroenterol; 2014 Apr; 49(4):589-93. PubMed ID: 24531873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]